Divi's Laboratories Limited
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients
What Divi's files
- Others53
- Investor Meet24
- Important9
- Board Meeting9
- Dividend/Bonus4
- Results1
Divi's Laboratories has proposed a final dividend of ₹30 per equity share (1500% on ₹2 face value) for the financial year 2025-26. This payout awaits shareholder approval at the 36th Annual General Meeting on August 10, 2026. Mark your calendars: July 24, 2026, is the record date to determine eligibility...
Divi's Laboratories' Board has proposed a final dividend of ₹30 per equity share (face value ₹2) for FY2025-26. This payout, equaling 1500%, is subject to shareholder approval at the upcoming 36th Annual General Meeting on August 10, 2026. The record date for dividend eligibility is July 24, 2026. Shareholders will...
The company has announced a record date for shareholders to be eligible for the upcoming dividend payout. Shareholders holding shares on this date will receive the declared dividend. This corporate action ensures clarity on who qualifies for the dividend distribution. Any changes to the record date or eligibility criteria will...
Divi's Laboratories has announced a final dividend of ₹30 per share (1500%), subject to shareholder approval. Shareholders recorded by the cut-off will receive the payout after the AGM. Strong profitability supports this payout, with consolidated PAT at ₹2,191 Cr and standalone PAT at ₹2,209 Cr for the year. Commercial operations...